Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Rhode Island Medical Journal (2013)
|
June 25, 2024
Pathways to Medicine
Jasmine Gibson, Amalia Bay, Luckson Omoaregba, et al.
Cancer Letters
|
November 17, 2023
Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase
Katsuya Nagaoka, Xuewei Bai, Dan Liu, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2020
Ten-Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild-Type Isocitrate Dehydrogenase 1
Xuewei Bai, Hongyu Zhang, Yamei Zhou, et al.
EMBO Molecular Medicine
|
March 31, 2025
Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
Hongze Chen, Muhammad Azhar Nisar, Joud Mulla, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Rhode Island Medical Journal (2013)
|
June 25, 2024
Pathways to Medicine
Jasmine Gibson, Amalia Bay, Luckson Omoaregba, et al.
Cancer Letters
|
November 17, 2023
Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase
Katsuya Nagaoka, Xuewei Bai, Dan Liu, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2020
Ten-Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild-Type Isocitrate Dehydrogenase 1
Xuewei Bai, Hongyu Zhang, Yamei Zhou, et al.
EMBO Molecular Medicine
|
March 31, 2025
Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
Hongze Chen, Muhammad Azhar Nisar, Joud Mulla, et al.
Page
of 1